Executive VP, Innovation & Dissemination , Geisinger Health System
Earl Steinberg, MD, is Executive VP of Innovation & Dissemination at Geisinger Health System, as well as CEO of xG Health Solutions. Steinberg is a nationally known expert in evaluation and improvement of the quality and efficiency of healthcare. In addition to his CEO responsibilities, Dr. Steinberg is also Geisinger’s Executive Vice President of Innovation & Dissemination, and Chief, Healthcare Solutions Enterprise. Prior to joining Geisinger, Dr. Steinberg was Senior Vice President for Clinical Strategy, Quality and Outcomes at WellPoint, Inc., and President and CEO of Resolution Health Inc. (RHI), a leading healthcare data analysis company that provides innovative quality improvement and cost reduction services to health plans, employers, PBMs and disease management companies.
Dr. Steinberg also is an Adjunct Professor of Medicine and of Health Policy and Management at Johns Hopkins University. Prior to joining RHI, Dr. Steinberg spent six years as Vice President of Covance Health Economics and Outcomes Services Inc., Director of its Quality Assessment and Improvement Systems (QAIS) Division, and Co-Director of its Outcomes Studies Group (OSG). Dr. Steinberg also spent 12 years on the full-time faculty at Johns Hopkins University, where he was Professor of Medicine and of Health Policy and Management as well as Director of The Johns Hopkins Program for Medical Technology and Practice Assessment. Dr. Steinberg also served four years on the Federal Physician Payment Review Commission (PPRC).
Dr. Steinberg received his A.B. degree from Harvard College (Summa Cum Laude), his M.D. from Harvard Medical School and a Master of Public Policy degree from the Kennedy School of Government. His residency training in internal medicine was performed at the Massachusetts General Hospital.
Dr. Steinberg has received numerous awards, including the Henry J. Kaiser Family Foundation Faculty Scholar Award in General Internal Medicine (1984), the “Outstanding Young Investigator” Award from the Association for Health Services Research (1988), and a Special Presidential Visionary Award from the National Kidney Foundation (2004) for his work as the scientific director of the NKF’s landmark Kidney Disease Outcomes and Quality Initiative, which produced over 250 clinical practice guidelines for management of patients with end stage renal disease. He is also a Fellow of both the American College of Physicians and Academy Health and has published more than 125 articles in peer reviewed journals.